PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Takeda Pharmaceutical Co's PE Ratio without NRI is 32.91. Takeda Pharmaceutical Co's 5-Year EBITDA growth rate is 10.00%. Therefore, Takeda Pharmaceutical Co's PEG Ratio for today is 3.29.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Takeda Pharmaceutical Co's PEG Ratio or its related term are showing as below:
TAK'
s PEG Ratio Range Over the Past 10 Years
Min: 1.39 Med: 3.21 Max: 283.56
Current: 3.29
During the past 13 years, Takeda Pharmaceutical Co's highest PEG Ratio was 283.56. The lowest was 1.39. And the median was 3.21.
TAK's PEG Ratio is ranked worse than 76.14% of 373
companies
in the Drug Manufacturers industry
Industry Median: 1.64
vs TAK: 3.29
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Takeda Pharmaceutical Co PEG Ratio Historical Data
The historical data trend for Takeda Pharmaceutical Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Takeda Pharmaceutical Co's PEG Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takeda Pharmaceutical Co's PEG Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Takeda Pharmaceutical Co's PEG Ratio falls into.
Takeda Pharmaceutical Co PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
Takeda Pharmaceutical Co's PEG Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Takeda Pharmaceutical Co (NYSE:TAK) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Takeda Pharmaceutical Co PEG Ratio Related Terms
Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.
Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TAK has been successfully added to your 